PEOPLE - ReGen Biologics in the US makes appointment:
This article was originally published in Clinica
ReGen Biologics in the US has appointed Gerald Bisbee chairman, president and CEO. Dr Bisbee was most recently with APACHE Medical Systems, a provider of FDA advisory services. ReGen Biologics manufactures minimally invasive implants for knee joint repair and preservation.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.